A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of ...

Moderna Inc. Chief Executive Officer Stephane Bancel said he sees the pending launch of a planned flu vaccine as a chance to ...

An experimental mRNA vaccine delayed neuroblastoma growth and sharply reduced tumor size in preclinical models.

By Julie Steenhuysen CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and entertainment news.

Moderna just received fantastic news.

Vaccines using mRNA technology weren’t immune to the latest round of federal research cuts. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he’s pulling the plug on ...

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

Raina Biosciences Inc. (Raina), an mRNA technology and therapeutics company, has released data from its generative AI platform in Science. The data supports Raina's pioneering approach to mRNA design ...

Preclinical study demonstrates effectiveness of experimental mRNA vaccine against neuroblastoma, reducing tumour size by 70 ...